Maia Anderson - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Maia Anderson's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Maia Anderson

Maia Anderson

Verified

Senior Reporter, Healthcare Brew

Doesn’t Cover

consumer technology, business technology

Journalist Type

-

Seniority Positions

Industries

Medium Formats

-

Content

Total articles 2959

  • Sycamore Partners’ plan to takeover Walgreens ‘incredibly risky,’ analyst says

    By Maia Anderson Verified| Healthcare Brew Verified Walgreens is entering its private company era with Sycamore Partners’s take-private deal, announced in early March, to buy it for at least $22 billion. While getting off the public market can have its perks, analysts say the Walgreens Boots Alliance deal with the private equity (PE) firm could be risky, as it saddles the retail pharmacy giant with a significant amount of debt.

    By Maia Anderson Verified · Healthcare Brew

    Apr. 15, 2025

  • CVS names 2 new execs amid turnaround strategy

    By Maia Anderson Verified| Healthcare Brew Verified CVS named two new executives to its leadership team as the company tries to bounce back from a year that saw its net income cut nearly in half. The retail pharmacy giant named UPS veteran Brian Newman as its new EVP and CFO and Press Ganey expert Amy Compton-Phillips as its new EVP and chief medical officer. Newman will take over the role on April 21 and Compton-Phillips starts on May 19, CVS announced on April 8.

    By Maia Anderson Verified · Healthcare Brew

    Apr. 10, 2025

  • Sycamore Partners’ plan to takeover Walgreens ‘incredibly risky,’ analyst says

    By Maia Anderson Verified| Healthcare Brew Verified Walgreens is entering its private company era with Sycamore Partners’s take-private deal, announced in early March, to buy it for at least $22 billion. While getting off the public market can have its perks, analysts say the Walgreens Boots Alliance deal with the private equity (PE) firm could be risky, as it saddles the retail pharmacy giant with a significant amount of debt.

    By Maia Anderson Verified · Healthcare Brew

    Apr. 15, 2025

As seen in

Company Info

Healthcare Brew

United States